We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0K1R
​
​
logo

Viridian Therapeutics (0K1R)

LSE • 0K1R • US92790C1045

29.03Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 1.8% of free float sold short, 1,292.5 days to cover, cost to borrow 0.52%. Sign up for live short interest data.

Market Cap

3.23b USD | # 1508 in GB

Volume

1.55k shares | 45.67m USD

Shares Outstanding

113.56m

Free Float Shares

88.99% | 101.05m

Nasdaq:VRDN|
DB:1S1

News

0K1R key data

Viridian Therapeutics (LSE: 0K1R) has a market capitalization of $3.23B. Last close $29.03 (as of 2026-11-09); 52-week range $13.25 to $34.31. ORTEX data as of 2026-10-22: short interest was 1.77% of free float, 1,292.5 days to cover and the average cost to borrow was 0.52%. Sign up for live short interest data.

  • 0K1R news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.